aPROMISE: a novel automated PROMISE platform to standardize evaluation of tumor burden in 18F-DCFPyL images of veterans with prostate cancer
Standardized staging and quantitative reporting are necessary to demonstrate the
association of 18F-DCFPyL PET/CT imaging with clinical outcome. This work introduces an …
association of 18F-DCFPyL PET/CT imaging with clinical outcome. This work introduces an …
Potential impact of 68Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer
Standard-of-care imaging for initial staging of prostate cancer (PCa) underestimates disease
burden. Prostate-specific membrane antigen (PSMA) PET/CT detects PCa metastasis with …
burden. Prostate-specific membrane antigen (PSMA) PET/CT detects PCa metastasis with …
[HTML][HTML] Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized …
K Johnsson, J Brynolfsson, H Sahlstedt… - European Journal of …, 2022 - Springer
Purpose The application of automated image analyses could improve and facilitate
standardization and consistency of quantification in [18F] DCFPyL (PSMA) PET/CT scans. In …
standardization and consistency of quantification in [18F] DCFPyL (PSMA) PET/CT scans. In …
Detection rate of 18F-rhPSMA-7.3 PET in patients with suspected prostate cancer recurrence: Results from a phase 3, prospective, multicenter study (SPOTLIGHT)
DM Schuster, SPOTLIGHT Study Group - 2022 - ascopubs.org
9 Background: 18F-labeled prostate-specific membrane antigen (PSMA) positron emission
tomography (PET) ligands offer a longer half-life and improved spatial resolution compared …
tomography (PET) ligands offer a longer half-life and improved spatial resolution compared …
Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter-and intrareader agreement
PET using radiolabeled prostate-specific membrane antigen (PSMA) is now being more
widely adopted as a valuable tool to evaluate patients with prostate cancer (PC). Recently, 3 …
widely adopted as a valuable tool to evaluate patients with prostate cancer (PC). Recently, 3 …
Matched-pair comparison of 18F-DCFPyL PET/CT and 18F-PSMA-1007 PET/CT in 240 prostate cancer patients: interreader agreement and lesion detection rate of …
M Wondergem, FM van der Zant… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Over 20 different prostate-specific membrane antigen (PSMA)–targeting
radiopharmaceuticals for both imaging and therapy have been synthesized. Although …
radiopharmaceuticals for both imaging and therapy have been synthesized. Although …
[HTML][HTML] Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
MCF Cysouw, BHE Jansen, T van de Brug… - European journal of …, 2021 - Springer
Purpose Quantitative prostate-specific membrane antigen (PSMA) PET analysis may
provide for non-invasive and objective risk stratification of primary prostate cancer (PCa) …
provide for non-invasive and objective risk stratification of primary prostate cancer (PCa) …
18F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary …
M Wondergem, FM Van Der Zant, WAM Broos… - European Journal of …, 2021 - Springer
Purpose Prostate-specific membrane antigen (PSMA) PET/CT shows better diagnostic
performance for detection of lymph node and bone metastases as compared to conventional …
performance for detection of lymph node and bone metastases as compared to conventional …
[HTML][HTML] Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in …
K Subramanian, J Martinez… - Scientific Reports, 2023 - nature.com
Prostate cancer (PC) staging with conventional imaging often includes multiparametric
magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest …
magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest …
[HTML][HTML] Freely Available, Fully Automated AI-Based Analysis of Primary Tumour and Metastases of Prostate Cancer in Whole-Body [18F]-PSMA-1007 PET-CT
Here, we aimed to develop and validate a fully automated artificial intelligence (AI)-based
method for the detection and quantification of suspected prostate tumour/local recurrence …
method for the detection and quantification of suspected prostate tumour/local recurrence …
Related searches
- prostate cancer tumor burden
- prostate cancer pet ct
- prostate cancer lesion detection
- prostate cancer 68ga psma
- prostate cancer risk stratification
- prostate cancer whole body
- prostate cancer radiation therapy
- pet ct primary tumour
- pet ct whole body
- lesion detection dcfpyl pet
- prostate cancer dcfpyl pet
- prostate cancer pet radiomics
- prostate cancer primary tumour